At a glance
Tenet Healthcare Corporation is worth $21.37B, about 17 times its fiscal 2025 earnings. Revenue grew 3.1% to $21.31B in fiscal 2025, with 6.6% kept as profit; over 5 years it has grown 3.9% a year. It pays no dividend; it spent $2.51B buying back its shares over FY2021–FY2025. The stock returned +31.2% over the past year with dividends reinvested, against +11.5% for the S&P 500.
The business in plain English
Tenet Healthcare, based in Dallas, Texas, runs hospitals, outpatient surgery centers and a billing services business. Health plans and government programs pay for most of the care it provides. In fiscal 2025, about 70% of net patient service revenue at its hospitals and related outpatient sites came from managed care payers. These are health plans that negotiate set rates with providers, including Medicare and Medicaid managed care plans.
Hospital Operations and Services brought in $16.1 billion in fiscal 2025, about 76% of total revenue of $21.3 billion. At December 31, 2025, it had 50 hospitals with 12,494 licensed beds in eight states. It also had 132 outpatient sites such as urgent care and imaging centers, and about 74% of them were in Arizona and Texas. The segment also includes Conifer Health Solutions, which handles insurance checks, coding, billing and collections for about 600 hospitals and other clients. Tenet returned to full ownership of Conifer effective January 1, 2026.
Ambulatory Care, run by the subsidiary USPI, produced $5.2 billion, about 24% of revenue. USPI held stakes in 533 ambulatory surgery centers, where patients usually go home the same day, and 26 surgical hospitals in 37 states. It builds and acquires these sites mainly through joint ventures with physicians and health systems. Common procedures include orthopedic and joint replacement surgery, digestive tract procedures, pain management, eye surgery and urology.
Price history
The interactive chart needs JavaScript.
THC +31.2% over the year to Oct 28, 2026, total return with dividends reinvested.
How it makes money
By business segment
| Hospital Operations | $16.14B | 75.7% |
| Ambulatory Care | $5.17B | 24.3% |
Latest results
- In Q3 FY2026 (ended Sep 30, 2026), revenue was $5.63B, up 6.5% from a year earlier, and net income was $1.00B (+192.4%).
- For fiscal 2025, revenue was $21.31B (+3.1% year over year; +3.9% a year from FY2020 to FY2025) with a 6.6% net margin.
Financial health check
| Revenue growth a year (FY2020–FY2025) | +3.9% watch |
|---|---|
| Operating margin | 16.5% good |
| Free cash flow margin | 11.9% good |
| Return on equity (FY2025) | 33.3% good |
| Return on assets (FY2025) | 4.7% watch |
| Net cash (cash minus debt) | $-10.57B weak |
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2020 | $17.64B | $399.0M | $2.87B |
| FY2021 | $19.48B | $914.0M | $910.0M |
| FY2022 | $19.17B | $411.0M | $321.0M |
| FY2023 | $20.56B | $611.0M | $1.62B |
| FY2024 | $20.68B | $3.20B | $1.12B |
| FY2025 | $21.31B | $1.41B | $2.53B |
Valuation snapshot
| Market value | $21.37B |
|---|---|
| P/E ratio | 17.3 |
| Dividend yield | None |
Rank among 1514 US companies
Market value at each year end
Tenet Healthcare’s market value went from $5.28B at the end of 2022 to $21.37B on Oct 28, 2026, about 4.1 times as much; since the end of 2025 it is up 22%.
Show as a table
| Year end | Market value | Change |
|---|---|---|
| Oct 28, 2026 | $21.37B | +22.4% |
| 2025 | $17.46B | +45.5% |
| 2024 | $12.00B | +56.4% |
| 2023 | $7.67B | +45.5% |
| 2022 | $5.28B |
Price behavior
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | |
|---|---|---|---|---|---|
| THC price data to Oct 28, 2026 | +35.1% | +31.2% | +71.6% | — | — |
Show as a table
| Year | Price data |
|---|---|
| 2026 (to date) | +35.1% |
| 2025 | +57.4% |
| 2024 | +67.0% |
| 2023 | +54.9% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before this security existed |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Before this security existed |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Before this security existed |
Insider activity
Form 4 filings from 2025-10-30 to 2026-10-30 (25 read): 0 open-market purchases and 25 sales ($51.5M).
| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 24, 2026 | Saumya Sutaria CEO, Director | sell | $10.2M |
| Aug 25, 2026 | Saumya Sutaria CEO, Director | sell | $6.8M |
| Aug 31, 2026 | Lisa Y Foo EVP, Chief Operating Officer | sell | $6.4M |
| Aug 25, 2026 | Saumya Sutaria CEO, Director | sell | $4.7M |
| Aug 24, 2026 | Saumya Sutaria CEO, Director | sell | $3.7M |
Who owns it
Large shareholders (13G filings)
| BlackRock, Inc. | 10% | Aug 31, 2026 |
| T. Rowe Price Associates, Inc. | 9.2% | Jun 30, 2026 |
| Vanguard Capital Management | 5.26% | Mar 31, 2026 |
| FMR LLC | 4.6% | Jun 30, 2026 |
| Invesco Ltd. | 4.4% | Mar 31, 2025 |
ETFs with the most weight in THC
| TXS Texas Capital Texas Equity Index ETF | 5.17% |
| FXH First Trust Health Care AlphaDEX Fund | 2.25% |
| XMHQ Invesco S&P MidCap Quality ETF | 2.25% |
| SMRI Bushido Capital US Equity ETF | 2.09% |
| QVAL Alpha Architect U.S. Quantitative Value ETF | 2.06% |
| XHS SPDR S&P Health Care Services ETF | 2.04% |
| SMDX Intech S&P Small-Mid Cap Diversified Alpha ETF | 1.86% |
| IHF iShares U.S. Healthcare Providers ETF | 1.79% |
What could go wrong
- Heavy reliance on a few health plans. About 70% of fiscal 2025 hospital patient revenue came from managed care payers, and the top 10 supplied 69% of that. Lower rates, payment denials or a lost contract could hurt results.
- Concentrated in a few states. Its 50 hospitals were in eight states at the end of 2025, and about 74% of its hospital-segment outpatient centers were in Arizona and Texas. Local downturns, disasters or rule changes there could hurt results.
- A large debt load. Total debt was about $13.2 billion as of June 30, 2026, against $2.2 billion of cash and investments. Heavy debt can limit flexibility in a downturn, and lender rules called covenants restrict some actions.
- Dependence on doctors and joint venture partners. USPI builds and acquires surgery centers mainly through joint ventures with physicians and health systems. Losing key partners or failing to attract needed specialists could reduce patient volumes and slow growth.
- Health policy changes could shrink paying patients. Some expanded Affordable Care Act provisions expired at the end of 2025, and Tenet expects more uninsured people from 2026. Changes or cuts to Medicare and Medicaid could also hurt results.
- Rising labor costs and staff shortages. Competition for staff, a shortage of experienced nurses and other health workers, and union activity have raised Tenet's labor costs. The company warns this may continue.
Recent events
- Quarterly results released
- Major agreement signed; New debt or financial obligation
- Investor presentation or announcement; Other company announcement
- Quarterly results released
- Shareholder vote results
- Quarterly results released
- Executive or board change
- Executive or board change
- Quarterly results released
- Quarterly results released; Investor presentation or announcement; Other company announcement
For income and retirement investors
Tenet paid no dividends from fiscal 2021 through fiscal 2025 and had no dividend yield as of October 28, 2026. That means the stock offers no regular income, and an income investor would need to sell shares to raise cash. Tenet returns cash through buybacks instead. These totaled about $2.5 billion over those five years, including $1.39 billion in fiscal 2025. The share count fell about 25%, from roughly 107.1 million in October 2021 to 80.5 million in July 2026, so each remaining share gets a bigger slice of profits.
Our price record for Tenet covers about 4.1 years to October 28, 2026. It does not cover the 2008 financial crisis, the 2020 COVID crash or the 2022 bear market. Within that record, the deepest drop from a peak was about 37%. The shares also fell about 34% at one point in the year to that date. Single stocks carry more risk than diversified funds.
Questions investors ask
How does Tenet Healthcare make money?
Mostly by treating patients and collecting from health plans and government programs. In fiscal 2025, its Hospital Operations segment produced about 76% of $21.3 billion in revenue. At year-end it had 50 hospitals and 132 outpatient sites. That segment also includes Conifer Health Solutions, which handles billing, coding and collections for about 600 hospitals and other clients. Ambulatory Care, run by USPI, produced about 24%. USPI held stakes in 533 surgery centers and 26 surgical hospitals.
Does Tenet Healthcare pay a dividend?
No. Tenet paid no dividends from fiscal 2021 through fiscal 2025 and had no dividend yield as of October 28, 2026. It returns cash to shareholders through stock buybacks instead. It spent about $2.5 billion on buybacks over those five years, including $1.39 billion in fiscal 2025. That helped cut the share count by about 25% between October 2021 and July 2026. Investors who need regular income would get none directly from this stock.
How has Tenet Healthcare stock performed?
It has risen sharply, with big swings. As of October 28, 2026, the share price was up about 31% over one year and about 405% over three years, or roughly 72% a year. The price rose about 55% in 2023, 67% in 2024 and 57% in 2025. In 2026 it was up about 35% year to date. The stock also fell about 34% from a peak at one point in the year to that date. Past gains may not repeat.
How much debt does Tenet Healthcare have?
About $13.2 billion in total debt as of June 30, 2026. It had about $2.2 billion of cash and investments, which left net debt of about $11.1 billion. Shareholders' equity was about $4.7 billion. Tenet's 10-K annual report warns that this debt could limit its ability to raise capital and respond to downturns. Rules set by lenders, called covenants, also restrict some of its actions. A filing dated September 22, 2026 reported a major agreement and a new debt obligation.
Which ETFs hold Tenet Healthcare stock?
Tenet appears in about 125 ETFs. The funds that give it the most weight include Texas Capital Texas Equity Index ETF (TXS) at about 5.2%. First Trust Health Care AlphaDEX Fund (FXH) and Invesco S&P MidCap Quality ETF (XMHQ) hold about 2.3% each. SPDR S&P Health Care Services ETF (XHS) holds about 2.0% and iShares U.S. Healthcare Providers ETF (IHF) about 1.8%. Fund weights change over time. A fund spreads risk across many companies rather than relying on one hospital operator.